By Adriano Marchese Iovance Biotherapeutics shares rose after the company received positive data from a clinical trial of its cancer treatment. Shares traded 11% higher ahead of the morning...
Iovance Biotherapeutics Stock Rises Premarket on Positive Trial Data for Cancer Drug